The session below was sponsored by Takeda during the ESPID 2026 Meeting and is intended for HCPs only.
*Not included in the main event CME/CPD credit.

Session Description:

This session will bring together global clinical and real world perspectives to explore why dengue’s unpredictable severity demands earlier, more proactive prevention. By connecting frontline experience with emerging evidence and decision making challenges from endemic and non endemic settings, the session aims to move clinicians from urgency to confident action in routine dengue prevention conversations.

10145

Francesca Norman
(Spain)

Dr Francesca F. Norman, MBBS, BMedSci, PhD, FISTM Graduated from St Bartholomew´s and the Royal London School of Medicine in London (1997), obtained an intercalated degree (BMedSci) in Medical Science and MRCP (UK).

Julio Croda
(Brazil)

Dr Julio Croda is an infectious-disease physician and epidemiologist at Fiocruz, Associate Professor of Internal Medicine at the Federal University of Mato Grosso do Sul, as well as Adjunct Associate Professor of Epidemiology at Yale School of Public Health.

Vanesa E. Castellano
(Argentina)

Vanesa Edelvais Castellano, MD, is a pediatrician specialized in vaccinology, epidemiology, and real-world evidence.

Wanatpreeya Phongsamart (Thailand)

Dr. Wanatpreeya Phongsamart is an Associate Professor of Pediatric Infectious Diseases at the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Note that this recording is intended for HCPs only.

 

This promotional symposium has been commissioned and funded by GSK and is for Healthcare Professionals only.
*Not included in the main event CME/CPD credit.

Session Description:

Adolescence is a pivotal moment — full of promise, but also a second window of vulnerability to Invasive Meningococcal Disease. Join us for a thought-provoking symposium that brings patient voices and real-world lessons together to spark change. Watch a video testimony from people and families whose lives have been impacted by meningitis. Learn how epidemiologic patterns and MenB incidence rates are relevant to a new cohort of patients entering adolescence across Europe, and beyond. Hear about Italy’s flexible, regional choices and the real-world results seen in South Australia more than five years after its adolescent program rollout. Finally, discover a path forward: GSK studies on duration of protection and the human impact on adolescents and caregivers that aim to close data gaps and accelerate adoption. This session is intended for Healthcare Professionals and Other Relevant Decision Makers. It would be of particular interest to paediatricians, clinicians, immunization leads, as well as policy makers. Leave inspired, equipped with real examples and next steps.

Teresa Bruce
(USA)

Teresa Bruce is a GSK Global Medical Director for the Neisseria portfolio – with 6 years experience raising awareness, developing strategy and sharing medical data on Invasive Meningococcal Disease and two years heading GSK medical external engagement in adult immunization.

Giovanni Gabutti
Italy

Prof. Giovanni Gabutti is Full Professor of Hygiene and Preventive Medicine at the University of Ferrara, where he has also served as Chief of the Specialization School of Hygiene and Preventive Medicine.

Helen Marshall
(Australia)

Professor Marshall AM is a clinician researcher and NHMRC Investigator L2 Fellow. She is a Consultant and Professor in Vaccinology in the College of Health and Clinical Research Director, Women’s and Children’s Health Network.

Chiara Azzari
(Italy)

Prof. Chiara Azzari is Full Professor of Pediatrics at the University of Florence and Director of the Pediatric Clinic II, as well as the Regional Reference Centre for Pediatric Immunology in Tuscany.

Note that this recording is intended for HCPs only.